- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A metabolomic approach to identifying platinum resistance in ovarian cancer ; volume:8 ; number:1 ; day:26 ; month:3 ; year:2015 ; pages:1-14 ; date:12.2015
Journal of ovarian research ; 8, Heft 1 (26.3.2015), 1-14, 12.2015
- Creator
-
Poisson, Laila M.
Munkarah, Adnan
Madi, Hala
Datta, Indrani
Hensley-Alford, Sharon
Tebbe, Calvin
Buekers, Thomas
Giri, Shailendra
Rattan, Ramandeep
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-015-0140-8
- URN
-
urn:nbn:de:101:1-2021080719400449303979
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Poisson, Laila M.
- Munkarah, Adnan
- Madi, Hala
- Datta, Indrani
- Hensley-Alford, Sharon
- Tebbe, Calvin
- Buekers, Thomas
- Giri, Shailendra
- Rattan, Ramandeep
- SpringerLink (Online service)
Other Objects (12)
Platinum resistance in breast and ovarian cancer cell lines
Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
Systematic analysis of ovarian cancer platinum-resistance mechanisms via text mining
Plasma metabolomic characterization of premature ovarian insufficiency
Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
Enhancing precision medicine: a nomogram for predicting platinum resistance in epithelial ovarian cancer
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer
C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation
Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer
Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer
Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer
Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition
Platinum resistance in breast and ovarian cancer cell lines
Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
Systematic analysis of ovarian cancer platinum-resistance mechanisms via text mining
Plasma metabolomic characterization of premature ovarian insufficiency
Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
Enhancing precision medicine: a nomogram for predicting platinum resistance in epithelial ovarian cancer
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer
C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation
Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer
Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer
Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer
Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition
Platinum resistance in breast and ovarian cancer cell lines
Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
Systematic analysis of ovarian cancer platinum-resistance mechanisms via text mining
Plasma metabolomic characterization of premature ovarian insufficiency
Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
Enhancing precision medicine: a nomogram for predicting platinum resistance in epithelial ovarian cancer
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer
C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation
Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer
Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer
Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer